linagliptin

Eli Lilly and Boehringer Ingelheim Pharmaceuticals said today the Food and Drug Administration has approved their diabetes drug Tradjenta, also known as linagliptin.

Pfizer Sickly After Earnings, Lilly Gets Diabetes Clearance 2011

The split ends a decades-long partnership that appeared to unravel after Lilly signed a deal earlier this year with Boehringer Ingelheim to jointly develop and sell several diabetes compounds that are in mid- and late-stage development, including a Boehringer oral diabetes agent known as linagliptin.

unknown title 2011

Eli Lilly and Boehringer Ingelheim Pharmaceuticals said today the Food and Drug Administration has approved their diabetes drug Tradjenta, also known as linagliptin.

Forbes.com: News MarketNewsVideo.com 2011

The approval of linagliptin in Europe was based on a clinical trial program which involved approximately 6,000 adults with type 2 diabetes.

unknown title 2011

"This means that linagliptin is available at only one dose."

unknown title 2011

In the U.S., linagliptin 5 mg is marketed under the trade name Tradjenta™ (linagliptin) tablets and was approved by the U.S. Food and Drug Administration (FDA) in

unknown title 2011

"We are delighted that linagliptin will soon be available to patients across Europe."

unknown title 2011

There is no guarantee that future study results and patient experience will be consistent with study findings to date or that linagliptin will be commercially successful.

unknown title 2011

The European Commission has approved linagliptin in combination with metformin and metformin plus sulfonylurea.

unknown title 2011

"The EU approval of linagliptin marks another major regulatory milestone for the Boehringer Ingelheim and Lilly alliance in diabetes," said

unknown title 2011